183 related articles for article (PubMed ID: 1244791)
1. Lidocaine in Wolff-Parkinson-White syndrome with atrial fibrillation.
Josephson ME; Kastor JA; Kitchen JG
Ann Intern Med; 1976 Jan; 84(1):44-5. PubMed ID: 1244791
[TBL] [Abstract][Full Text] [Related]
2. Treatment of arrhythmias in the Wolff-Parkinson-White syndrome.
Forester D
Chest; 1979 Jun; 75(6):745. PubMed ID: 436537
[No Abstract] [Full Text] [Related]
3. Ventricular fibrillation in Wolff-Parkinson-White syndrome, type A.
Papa LA; Saia JA; Chung EK
Heart Lung; 1978; 7(6):1015-9. PubMed ID: 251167
[TBL] [Abstract][Full Text] [Related]
4. [Lidocaine administration in a patient with Wolff-Parkinson-White syndrome and atrial fibrillation (author's transl)].
Rusconi L; Sermasi S; Marzaloni M; Rossi F
G Ital Cardiol; 1979; 9(4):428-33. PubMed ID: 456804
[TBL] [Abstract][Full Text] [Related]
5. Treatment of cardiac arrhythmias.
Robinson SJ
Pediatr Clin North Am; 1964 May; 11(2):315-62. PubMed ID: 4174540
[No Abstract] [Full Text] [Related]
6. Transient appearance of antegrade conduction via an AV accessory pathway caused by atrial fibrillation in a patient with intermittent Wolff-Parkinson-White syndrome.
Niwano S; Kitano Y; Moriguchi M; Izumi T
Heart; 2000 May; 83(5):E8. PubMed ID: 10768920
[TBL] [Abstract][Full Text] [Related]
7. Effects of procainamide and quinidine sulfate in the Wolff-Parkinson-White syndrome.
Sellers TD; Campbell RW; Bashore TM; Gallagher JJ
Circulation; 1977 Jan; 55(1):15-22. PubMed ID: 830205
[TBL] [Abstract][Full Text] [Related]
8. [Contraindications to the use of digitalis in atrial fibrillation in the course of Wolff-Parkinson-White syndrome].
Bracchetti D; Binetti G; D'Osualdo F; Magnani B
Boll Soc Ital Cardiol; 1974; 19(2):181-6. PubMed ID: 4462802
[No Abstract] [Full Text] [Related]
9. ST segment elevation in the right precordial leads induced with class IC antiarrhythmic drugs: insight into the mechanism of Brugada syndrome.
Fujiki A; Usui M; Nagasawa H; Mizumaki K; Hayashi H; Inoue H
J Cardiovasc Electrophysiol; 1999 Feb; 10(2):214-8. PubMed ID: 10090224
[TBL] [Abstract][Full Text] [Related]
10. Atrial fibrillation in the Wolff-Parkinson-White syndrome: effects of verapamil and procainamide.
Laufer N; Crevey B
Ariz Med; 1985 Mar; 42(3):150-3. PubMed ID: 3994532
[No Abstract] [Full Text] [Related]
11. Evaluation of flecainide acetate in rapid atrial fibrillation complicating Wolff-Parkinson-White syndrome.
Kappenberger LJ; Fromer MA; Shenasa M; Gloor HO
Clin Cardiol; 1985 Jun; 8(6):321-6. PubMed ID: 4006340
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic therapy of tachyarrhythmias in patients with Wolff-Parkinson-White syndrome.
Prystowsky EN
Herz; 1983 Jun; 8(3):133-43. PubMed ID: 6135656
[No Abstract] [Full Text] [Related]
13. Magnesium reversal of digoxin-facilitated ventricular rate during atrial fibrillation in the Wolff-Parkinson-White syndrome.
Merrill JJ; DeWeese G; Wharton JM
Am J Med; 1994 Jul; 97(1):25-8. PubMed ID: 8030653
[TBL] [Abstract][Full Text] [Related]
14. Acceleration of the ventricular response during atrial fibrillation in the Wolff-Parkinson-White syndrome after verapamil.
Gulamhusein S; Ko P; Carruthers SG; Klein GJ
Circulation; 1982 Feb; 65(2):348-54. PubMed ID: 7053894
[TBL] [Abstract][Full Text] [Related]
15. [Wolff-Parkinson-White syndrome accompanying rapid conduction atrial fibrillation].
Mélon P; Waleffe A; Kulbertus H
Rev Med Liege; 1997 Nov; 52(11):698-702. PubMed ID: 9480494
[No Abstract] [Full Text] [Related]
16. Tachyarrhythmias in Wolff-Parkinson-White syndrome. Treatment and prevention.
Tonkin AM; Gallagher JJ; Wallace AG
JAMA; 1976 Mar; 235(9):947-9. PubMed ID: 946127
[No Abstract] [Full Text] [Related]
17. Effect of drugs in the wolff-parkinson-white syndrome.
Wellens HJ
Adv Cardiol; 1975; 14():233-40. PubMed ID: 1136886
[TBL] [Abstract][Full Text] [Related]
18. Challenging the superiority of amiodarone for rate control in Wolff-Parkinson-White and atrial fibrillation.
Simonian SM; Lotfipour S; Wall C; Langdorf MI
Intern Emerg Med; 2010 Oct; 5(5):421-6. PubMed ID: 20437113
[TBL] [Abstract][Full Text] [Related]
19. Intermittent Wolff-Parkinson-White syndrome due to phase 3 and phase 4 block: disappearance of rapid ventricular response during atrial fibrillation.
Fujiki A; Yoshida S; Tani M; Sasayama S
J Electrocardiol; 1988 Jan; 21(1):77-82. PubMed ID: 3351413
[TBL] [Abstract][Full Text] [Related]
20. PAROXYSMAL ATRIAL FIBRILLATION IN WOLFF-PARKINSON-WHITE SYNDROME SIMULATING VENTRICULAR TACHYCARDIA.
YAHINI JH; ZAHAVI I; NEUFELD HN
Am J Cardiol; 1964 Aug; 14():248-54. PubMed ID: 14204772
[No Abstract] [Full Text] [Related]
[Next] [New Search]
